GlassScriptPhysician profile
Courtney Malone
NPI 1508236027
$1,177.04
in general payments reported to CMS, 2019-2025
16 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.77 · 2022: $101 · 2023: $158 · 2024: $416 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $226.13 | 2024-2025 | Dovato, Cabenuva |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $172.28 | 2024-2025 | Caplyta |
| Abbvie INC. | $125.89 | 2023-2025 | |
| Gilead Sciences, INC. | $125.00 | 2024 | Biktarvy |
| Otsuka America Pharmaceutical, INC. | $102.16 | 2022-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $94.29 | 2024 | Invega Sustenna, Spravato |
| Alkermes, INC. | $80.32 | 2022-2023 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $47.91 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $39.85 | 2024-2025 | Delstrigo, Pifeltro |
| Janssen Biotech, INC. | $36.61 | 2023 | Symtuza |
| Vanda Pharmaceuticals INC. | $36.33 | 2025 | Fanapt, Hetlioz |
| Genentech USA, INC. | $26.77 | 2021 | |
| Phathom Pharmaceuticals, INC. | $21.94 | 2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $14.44 | 2024 | Trintellix |
| Lundbeck LLC | $13.63 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $13.49 | 2024 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Courtney Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.